Known as histotripsy, the device not only kills cancer cells but also stimulates the immune system as an added defense.

After consulting with a machine learning tool, providers were able to more accurately determine whether patients had a complete response to chemotherapy.

The novel immunotherapy had increased rates of desensitization to peanut.

The technique has potential to change the way aortic aneurysm is monitored.

Participants from the University of Michigan Health-led study range in age, race and health conditions.

New findings show importance of carefully selecting patients for a critical care treatment requiring intense staffing, specialized equipment and advanced expertise.